CYSTARAN (Sigma-Tau Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the CYSTARAN drug offered from Sigma-Tau Pharmaceuticals, Inc.. This Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Sigma-Tau Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: cysteamine hydrochloride
SUBSTANCE NAME: CYSTEAMINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA]
ROUTE: OPHTHALMIC
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2012-12-30
END MARKETING DATE: 0000-00-00


CYSTARAN HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCYSTARAN from Sigma-Tau Pharmaceuticals, Inc.
LABELER NAME: Sigma-Tau Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6.5(mg/mL)
START MARKETING DATE: 2012-12-30
END MARKETING DATE: 0000-00-00
PRODUCT ID: 54482-020_ed04dacc-1245-403f-9041-2f52027e8ef4
PRODUCT NDC: 54482-020
APPLICATION NUMBER: NDA200740

Other CYSTEAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Sigma-Tau Pharmaceuticals, Inc.CYSTARAN